AKANDANASDAQ: AKAN

London, United Kingdom--(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has successfully completed sales of its securities under its existing Form F-3 shelf registration. The shelf registration statement had a $5 million capacity and allowed the Company to raise cash by selling stock and warrants into the open market.

Akanda (NASDAQ: AKAN ) stock is rocketing higher on Friday alongside heavy pre-market trading of the cannabis company's shares. This has more than 6.3 million shares of AKAN stock changing hands as of this writing.

London, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,057,600 common shares at $0.103 per share, priced at the Minimum Price under the Nasdaq rules. The pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.

In London, United Kingdom, Akanda Corp. (NASDAQ: AKAN) announced today that it has entered into a second securities purchase agreement with an accredited investor. The investor has agreed to purchase 2,491,381 common shares at a price of $0.1031 per share and 12,057,600 pre-funded warrants to purchase common shares at $0.103 per share in a registered direct offering priced at the Minimum Price under Nasdaq rules. The pre-funded warrants can be exercised immediately at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations outlined in the agreement.

Akanda Corp. (NASDAQ: AKAN) has successfully completed its registered direct offering, selling 2,491,381 common shares at $0.1031 per share and 21,756,922 pre-funded warrants at a price of $0.103 per share. The pre-funded warrants can be exercised for $0.0001 per share at any time, subject to certain ownership limitations.

Akanda Corp. has announced a securities purchase agreement with an accredited investor to buy 2,491,381 common shares and 21,756,922 pre-funded warrants in a registered direct offering priced at the minimum price under Nasdaq rules. The pre-funded warrants can be exercised immediately at a price of $0.0001 and have certain limitations on beneficial ownership.

Akanda (NASDAQ: AKAN) stock is rising on Friday despite receiving a non-compliance notice from the Nasdaq Exchange due to not meeting the minimum stockholders' equity requirement to stay listed.

Use these technical indicators when trading penny stocks The post The Penny Stock Trader's Guide to Technical Indicators appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.